What is the NYHA (New York Heart Association) classification based on AHA (American Heart Association) guidelines for heart failure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

NYHA Classification According to AHA Guidelines

The New York Heart Association (NYHA) functional classification is a subjective assessment by clinicians that gauges the severity of symptoms in patients with heart failure who are in stages C or D of the ACC/AHA heart failure staging system. 1

NYHA Classification System

  • Class I: No limitation of physical activity. Ordinary physical activity does not cause symptoms of heart failure (fatigue, dyspnea, or palpitations). 1

  • Class II: Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in symptoms of heart failure. 2

    • Some clinicians further subdivide Class II into:
      • Class IIA: Dyspnea after running or climbing ≥2 ramps of stairs
      • Class IIB: Dyspnea after fast walking or climbing 2 ramps of stairs 3
  • Class III: Marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes symptoms of heart failure. 1

  • Class IV: Unable to carry on any physical activity without symptoms of heart failure, or symptoms of heart failure at rest. 1

Relationship to ACC/AHA Heart Failure Stages

The NYHA classification complements but does not replace the ACC/AHA staging system for heart failure: 1

  • Stage A: At risk for heart failure but without symptoms, structural heart disease, or cardiac biomarkers of stretch or injury 1

    • Not classified by NYHA as these patients don't have heart failure
  • Stage B: Pre-heart failure with structural heart disease but no current or previous symptoms 1

    • Not classified by NYHA as these patients don't have symptomatic heart failure
  • Stage C: Structural heart disease with current or previous symptoms of heart failure 1

    • Can be classified as NYHA I, II, III, or IV depending on symptom severity
  • Stage D: Advanced heart failure with marked symptoms that interfere with daily life despite maximal medical therapy 1

    • Usually classified as NYHA III or IV

Clinical Implications of NYHA Classification

  • NYHA classification is an independent predictor of mortality in heart failure patients 1, 4

  • Patients with NYHA Class III-IV have significantly higher mortality rates (hazard ratio 1.29) and hospitalization rates (hazard ratio 1.16) compared to those with NYHA Class I-II 4

  • The classification is widely used to determine eligibility for treatment strategies and clinical trials 5, 6

Limitations of NYHA Classification

  • NYHA classification is subjective and can change frequently over short periods of time 1

  • There is substantial overlap in objective measures between NYHA classes:

    • NT-proBNP levels show 93% overlap between Class I and II 6
    • Left ventricular ejection fraction shows 88% overlap between classes 5
  • The classification may not adequately stratify risk, particularly in milder forms of heart failure 5, 6

  • In one study, 58% of patients initially classified as NYHA I changed functional class during the first year of follow-up 6

Clinical Application

  • Clinicians should specify NYHA classification at baseline after initial diagnosis and reassess after treatment throughout the continuum of care 1

  • A patient with symptomatic heart failure (Stage C) may become asymptomatic with treatment (NYHA Class I) but will still be categorized as Stage C heart failure 1

  • Treatment recommendations and prognostic assessments are often based on NYHA classification, making accurate classification important despite its limitations 2, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.